BMY
Bristol-Myers Squibb Company (BMY)
Healthcare • NYSE • $56.16-0.16%
- Symbol
- BMY
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Price
- $56.16
- Daily Change
- -0.16%
- Market Cap
- $114.68B
- Trailing P/E
- 15.73
- Forward P/E
- 9.14
- 52W High
- $62.89
- 52W Low
- $42.52
- Analyst Target
- $63.32
- Dividend Yield
- +4.49%
- Beta
- 0.26
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Opdualag for the treatment of unresectable or metastatic melanoma; and Camzyos to treat symptomatic obstructive HCM to improve functional capacity and s…
Company websiteResearch BMY on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.